Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECOND-LINE
NCT00931463Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Sep 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by The Kirby Institute. Started Sep 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00931463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931463.